Galen Partners is a leading healthcare venture capital firm based in Stamford, Connecticut. The firm focuses on equity investments in healthcare information technology/outsourcing, medical devices and specialty pharmaceutical companies. With nearly $1 billion under management raised through five funds, Galen has invested in more than 70 companies since 1990. The partnership seeks opportunities to actively participate as a lead investor in which it can provide between $10 million to $30 million of equity capital in healthcare related companies with established revenue. The firm continues a tradition of strategic collaboration and partnership with its portfolio company management teams. Galen’s capital and guidance has helped to build many healthcare market leaders including Dow Pharmaceutical Sciences (Valeant), EduNeering (Kaplan), Encore Medical (DJO), Lumenos (Wellpoint), MedAssets (MDAS), Medicode (United Healthcare), MiniMed (Medtronic), Ocular Sciences (CooperVision) and Pyxis (Cardinal Health).